AVINZA(R) Second Manufacturing Source Approved by FDA; Diversifies Supply Chain and Increases Production Capacity.
Business Wire › August 18, 2005
Linked as:
Extract
AVINZA(R) Second Manufacturing Source Approved by FDA; Diversifies Supply Chain and Increases Production Capacity.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGNDE) announced today that the company has received approval from the FDA for the production of AVINZA(R) (morphine sulfate extended-release capsules)...
See the full content of this document
Sponsored links
